AAAAAA
Results:
1-11
|
Results: 11
Authors:
Schuhmacher, M
Kohlhuber, F
Holzel, M
Kaiser, C
Burtscher, H
Jarsch, M
Bornkamm, GW
Laux, G
Polack, A
Weidle, UH
Eick, D
Citation: M. Schuhmacher et al., The transcriptional program of a human B cell line in response to Myc, NUCL ACID R, 29(2), 2001, pp. 397-406
Authors:
Laux, G
Citation: G. Laux, Cost-benefit analysis of newer versus older antidepressants - Pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants, PHARMACOPS, 34(1), 2001, pp. 1-5
Authors:
Pajic, A
Polack, A
Staege, MS
Spitkovsky, D
Baier, B
Bornkamm, GW
Laux, G
Citation: A. Pajic et al., Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch, J GEN VIROL, 82, 2001, pp. 3051-3055
Authors:
Muller, H
Moller, HJ
Stippel, A
Fric, M
Grunwald, F
Laux, G
Klemm, E
Biersack, HJ
Citation: H. Muller et al., SPECT patterns in probable Alzheimer's disease, EUR ARCH PS, 249(4), 1999, pp. 190-196
Authors:
Grabe, HJ
Wolf, T
Gratz, S
Laux, G
Citation: Hj. Grabe et al., The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: Implications for fitness to drive, NEUROPSYCHB, 40(4), 1999, pp. 196-201
Authors:
Delini-Stula, A
Baier, D
Kohnen, R
Laux, G
Philipp, M
Scholz, HJ
Citation: A. Delini-stula et al., Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor - Results of the drug utilization observation studies, PHARMACOPS, 32(2), 1999, pp. 61-67
Authors:
Kaiser, C
von Stein, O
Laux, G
Hoffmann, M
Citation: C. Kaiser et al., Functional genomics in cancer research: Identification of target genes of the Epstein-Barr virus nuclear antigen 2 by subtractive cDNA cloning and high-throughput differential screening using high-density agarose gels, ELECTROPHOR, 20(2), 1999, pp. 261-268
Authors:
Zimber-Strobl, U
Strobl, L
Hofelmayr, H
Kempkes, B
Staege, MS
Laux, G
Christoph, B
Polack, A
Bornkamm, GW
Citation: U. Zimber-strobl et al., EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in thepathogenesis of Burkitt's Lymphoma, CURR T MICR, 246, 1999, pp. 315-321
Authors:
Kaiser, C
Laux, G
Eick, D
Jochner, N
Bornkamm, GW
Kempkes, B
Citation: C. Kaiser et al., The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2, J VIROLOGY, 73(5), 1999, pp. 4481-4484
Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters
Authors:
Hofelmayr, H
Strobl, LJ
Stein, C
Laux, G
Marschall, G
Bornkamm, GW
Zimber-Strobl, U
Citation: H. Hofelmayr et al., Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters, J VIROLOGY, 73(4), 1999, pp. 2770-2780
Authors:
Laux, G
Citation: G. Laux, Indication of novel antidepressive drugs in the treatment of movement disorders, AKT NEUROL, 25, 1998, pp. S334-S335
Risultati:
1-11
|